✦ LIBER ✦

Compliance as an Explanatory Variable in Clinical Trials: Comment: Dose-Response Estimands

✍ Scribed by Scott L. Zeger and Kung-Yee Liang

Book ID: 125249486
Publisher: American Statistical Association
Year: 1991
Tongue: English
Weight: 384 KB
Volume: 86
Category: Article
ISSN: 0162-1459
DOI: 10.2307/2289708

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Compliance as an Explanatory Variable in

Compliance as an Explanatory Variable in Clinical Trials: Comment: Dose-Response Estimands

✍ Donald B. Rubin 📂 Article 📅 1991 🏛 American Statistical Association 🌐 English ⚖ 563 KB

Compliance as an Explanatory Variable in

Compliance as an Explanatory Variable in Clinical Trials: Comment

✍ Paul Meier 📂 Article 📅 1991 🏛 American Statistical Association 🌐 English ⚖ 683 KB

Compliance as an Explanatory Variable in

Compliance as an Explanatory Variable in Clinical Trials: Rejoinder

✍ B. Efron and D. Feldman 📂 Article 📅 1991 🏛 American Statistical Association 🌐 English ⚖ 260 KB

THE POPULATION RISK AS AN EXPLANATORY VA

THE POPULATION RISK AS AN EXPLANATORY VARIABLE IN RESEARCH SYNTHESIS OF CLINICAL TRIALS

✍ MARTIN W. McINTOSH 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 1017 KB

The population risk, for example the control group mortality rate, is an aggregate measurement of many important attributes of a clinical trial, such as the general health of the patients treated and the experience of the staff performing the trial. Plotting measurements of the population risk again